RGTPQ — RegenETP, Share News
0.000.00%
Last trade - 00:00FinancialsHighly SpeculativeMicro Cap
- $1.14m
- -$5.21m
- $0.81m
PolarityTE: Jumps after positive initial data from diabetic foot ulcer study
Brief: Polarityte Inc Says Diabetic Foot Ulcer Trial Met Primary And Secondary Endpoint
Brief: Polarityte Reports Q4 Revenue Of $3.59 Mln
Brief: Polarityte Says Believes It Remains On Track To File IND For SkinTE In H2 2021
Brief: PolarityTE Receives Allowance For Additional U.S. Patent
Brief: Gatemore Capital Management LLP Now Controls 3.7% Of The Common Stock Of PolarityTE Inc On A Fully Diluted Basis
Brief: PolarityTE Inc - Has Been Advised Through A Letter From Nasdaq That That It Has Regained Compliance With Minimum Bid Price Requirement
Brief: PolarityTE Announces Completion Of Target Enrollment In Diabetic Foot Ulcer Trial
Brief: Gatemore Says Submitted Letter To Polarityte, Demanding Production Of Certain Of Co's Books, Records
PolarityTE Inc: Falls on discounted stock offering
Brief: PolarityTE Announces $10 Mln Direct Offering
PolarityTE: Up on forming strategic review committee to raise shareholder value
Brief: PolarityTE Announces Formation Of Strategic Review Committee
Brief: Gatemore Capital Management LLP Sends Letter To Board Of Directors Of PolarityTE Inc
Brief: Polarityte Announces $8 Mln Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Brief: PolarityTE Receives Allowance for First U.S. Patent
U.S. STOCKS ON THE MOVE-Ashford Hospitality, Spring Bank Pharma, Ideanomics, China Online Education
Brief: Polarityte Reports Third Quarter 2020 Results
Brief: PolarityTE Announces Successful Completion Of Initial Pre-IND Interaction With U.S. FDA For SkinTE